In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor

被引:14
作者
Feleszko, W
Mlynarczuk, I
Nowis, D
机构
[1] Med Univ Warsaw, Ctr Biostruct Res, Dept Immunol, PL-002004 Warsaw, Poland
[2] Med Univ Warsaw, Med Univ Childrens Hosp, Dept Pediat Pneumonol Allerg Dis & Hematol, PL-01184 Warsaw, Poland
[3] Med Univ Warsaw, Ctr Biostruct Res, Dept Histol & Embryol, PL-002004 Warsaw, Poland
关键词
D O I
10.1016/S0014-5793(01)02736-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:219 / 220
页数:2
相关论文
共 7 条
[1]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[2]  
Feleszko W, 1999, INT J CANCER, V81, P560, DOI 10.1002/(SICI)1097-0215(19990517)81:4<560::AID-IJC10>3.3.CO
[3]  
2-Z
[4]   The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. [J].
Kureishi, Y ;
Luo, ZY ;
Shiojima, I ;
Bialik, A ;
Fulton, D ;
Lefer, DJ ;
Sessa, WC ;
Walsh, K .
NATURE MEDICINE, 2000, 6 (09) :1004-1010
[5]   Current perspectives on statins [J].
Maron, DJ ;
Fazio, S ;
Linton, MF .
CIRCULATION, 2000, 101 (02) :207-213
[6]   Cerivastatin - A review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia [J].
Plosker, GL ;
Dunn, CJ ;
Figgitt, DP .
DRUGS, 2000, 60 (05) :1179-1206
[7]   Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect [J].
Vincent, L ;
Chen, W ;
Hong, L ;
Mirshahi, F ;
Mishal, Z ;
Mirshahi-Khorassani, T ;
Vannier, JP ;
Soria, J ;
Soria, C .
FEBS LETTERS, 2001, 495 (03) :159-166